(AKBA) Akebia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Akebia Therapeutics | (AKBA) share price targets
Complete technical analysis of Akebia Therapeutics (AKBA) by charts plus indicators, forecast predictions and share price targets for Akebia Therapeutics (AKBA)
Akebia Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Akebia Therapeutics is 4101020
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Fri Jul 2025 | 3.93 | 3.98 | 4.08 | 3.91 | 0.666 times |
| 10 Thu Jul 2025 | 3.98 | 4.00 | 4.01 | 3.89 | 0.808 times |
| 09 Wed Jul 2025 | 3.99 | 3.74 | 4.01 | 3.72 | 1.151 times |
| 08 Tue Jul 2025 | 3.71 | 3.66 | 3.75 | 3.61 | 0.83 times |
| 07 Mon Jul 2025 | 3.63 | 3.62 | 3.77 | 3.57 | 0.953 times |
| 03 Thu Jul 2025 | 3.62 | 3.63 | 3.63 | 3.56 | 0.382 times |
| 02 Wed Jul 2025 | 3.63 | 3.58 | 3.75 | 3.48 | 1.126 times |
| 01 Tue Jul 2025 | 3.57 | 3.63 | 3.68 | 3.49 | 1.227 times |
| 30 Mon Jun 2025 | 3.64 | 3.67 | 3.74 | 3.63 | 0.696 times |
| 27 Fri Jun 2025 | 3.65 | 3.76 | 3.76 | 3.60 | 2.075 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 4, for a target of 3.8 or 3.68
Share price targets for Akebia Therapeutics (AKBA)
| Target Type | Value |
| Downside Target | 1.52 |
| Downside Target | 2.25 |
| Downside Target | 2.48 |
| Downside Target | 2.89 |
| Downside Target | 2.97 |
| Downside Target | 3.14 |
| Downside Target | 3.46 |
| Downside Target | 3.57 |
| Downside Target | 3.68 |
| Downside Target | 3.87 |
| Upside Target | 4.08 |
Intraday share price targets for Akebia Therapeutics (AKBA)
| Target Type | Value |
| Downside Intraday Target | 3.64 |
| Downside Intraday Target | 3.35 |
| Upside Intraday Target | 4.15 |
| Upside Intraday Target | 4.37 |
| Downside Intraday Target | 3.86 |
Weekly technical analysis of Akebia Therapeutics (AKBA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Fri Jul 2025 | 3.93 | 3.62 | 4.08 | 3.57 | 1.285 times |
| 03 Thu Jul 2025 | 3.62 | 3.67 | 3.75 | 3.48 | 0.541 times |
| 27 Fri Jun 2025 | 3.65 | 3.67 | 3.87 | 3.48 | 1.537 times |
| 20 Fri Jun 2025 | 3.68 | 3.56 | 3.68 | 3.46 | 0.46 times |
| 13 Fri Jun 2025 | 3.56 | 4.04 | 4.08 | 3.48 | 0.877 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Akebia Therapeutics (AKBA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Fri Jul 2025 | 3.93 | 3.63 | 4.08 | 3.48 | 0.235 times |
| 30 Mon Jun 2025 | 3.64 | 3.06 | 4.08 | 2.97 | 1.225 times |
| 30 Fri May 2025 | 3.03 | 2.41 | 3.14 | 2.25 | 1.239 times |
| 30 Wed Apr 2025 | 2.41 | 1.99 | 2.48 | 1.52 | 0.754 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Akebia Therapeutics (AKBA)
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Akebia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Akebia Therapeutics in short term but the sell signal is initial and weak.
Akebia Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Akebia Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.72 and Akebia Therapeutics (AKBA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Akebia Therapeutics (AKBA) stock. Volume based technical analysis of Akebia Therapeutics (AKBA) stock is negative.
Akebia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Akebia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Akebia Therapeutics in short term but the sell signal is initial and weak.
Akebia Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Akebia Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.72 and Akebia Therapeutics (AKBA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Akebia Therapeutics (AKBA) stock. Volume based technical analysis of Akebia Therapeutics (AKBA) stock is negative.
Akebia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.